In non-small cell lung cancer (NSCLC) cells, KAT8 upregulates p27 transcription by enhancing H4K16 acetylation (H4K16ac) in the S-phase kinase-associated protein 2 (SKP2) promoter, promoting S-phase progression and proliferation [10]. Here, KAT8 is linked to non-small cell lung carcinoma.